Vanden Plas asks Is Wisconsin's stem cell standing diminished?

To the question --Is Wisconsin's stem cell standing diminished?-- IPBiz answers: wait until the USPTO responds to what WARF has to say about the first Office Actions in the re-examinations of the WARF patents.

Vanden Plas writes: "for the first time since University of Wisconsin-Madison stem cell researcher James Thomson developed a method for isolating and defining human embryonic stem cells, some in Wisconsin are wondering whether the university actually has done something groundbreaking.

Republican State Rep. Stephen Nass was among the first to jab the most visible champions of the research, Gov. Jim Doyle and the university. Nass said the preliminary rejection by the patent office raises serious issues about past claims from UW-Madison officials to obtain public support and financing for stem cell research."

The quote attributed to Nass “It seems the priority is about money and not cures.” could also be applied to California's Proposition 71 and CIRM.

See also

First Office Action rejects claims of WARF's patents

See also

Patent Reward Systems – Its Not About The Money which includes

From the company’s side of things, the company’s biggest problem is always getting inventors to write down the initial disclosure. Without the disclosure, the process does not go forward and other people in the company cannot participate in protecting the idea.

IPBiz notes this statement about "biggest problem" might be disputed. Where have you gone, Richard K. Lyon?